tradingkey.logo

AVITA Medical Inc

RCEL
3.620USD
-0.160-4.23%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
96.34MValor de mercado
PerdaP/L TTM

AVITA Medical Inc

3.620
-0.160-4.23%

Mais detalhes de AVITA Medical Inc Empresa

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.

Informações de AVITA Medical Inc

Código da empresaRCEL
Nome da EmpresaAVITA Medical Inc
Data de listagemMar 18, 2012
CEOMr. James M. (Jim) Corbett
Número de funcionários260
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 18
Endereço28159 Avenue Stanford
CidadeVALENCIA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal91355
Telefone16613679170
Sitehttps://www.avitamedical.com/
Código da empresaRCEL
Data de listagemMar 18, 2012
CEOMr. James M. (Jim) Corbett

Executivos da empresa AVITA Medical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
17.90M
97.17%
Japan
427.00K
2.32%
United Kingdom
55.00K
0.30%
Australia
40.00K
0.22%
European Union (Region)
0.00
0.00%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: dom, 17 de ago
Atualizado em: dom, 17 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
Outro
82.17%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
Outro
82.17%
Tipos de investidores
Investidores
Proporção
Investment Advisor
16.21%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
3.40%
Research Firm
1.31%
Individual Investor
0.91%
Pension Fund
0.23%
Venture Capital
0.11%
Bank and Trust
0.10%
Insurance Company
0.03%
Outro
69.75%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
206
7.81M
29.34%
-1.85M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
1.74M
6.53%
+13.93K
+0.81%
Jun 30, 2025
The Vanguard Group, Inc.
1.45M
5.45%
+16.54K
+1.15%
Jun 30, 2025
Geode Capital Management, L.L.C.
618.34K
2.32%
-1.36K
-0.22%
Jun 30, 2025
State Street Investment Management (US)
528.78K
1.99%
+1.83K
+0.35%
Jun 30, 2025
UBS Financial Services, Inc.
409.80K
1.54%
+65.07K
+18.88%
Jun 30, 2025
Opaleye Management Inc.
389.52K
1.46%
-50.48K
-11.47%
Jun 30, 2025
Millennium Management LLC
369.19K
1.39%
+357.21K
+2980.45%
Jun 30, 2025
Northern Trust Investments, Inc.
242.03K
0.91%
-10.13K
-4.02%
Jun 30, 2025
Jacobs Levy Equity Management, Inc.
138.20K
0.52%
+92.23K
+200.61%
Jun 30, 2025
Wellington Management Company, LLP
110.70K
0.42%
+28.50K
+34.66%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Ver Mais
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.03%
iShares Micro-Cap ETF
Proporção0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
iShares Russell 3000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
iShares Russell 2000 ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Direxion Daily S&P Biotech Bull 3X Shares
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI